Phospho-PAK2 (S192) Antibody

What is PAK2 and why is phosphorylation at S192 significant?

PAK2 (p21-activated kinase 2) is a serine/threonine protein kinase that functions as a downstream effector of the small GTPases Cdc42 and Rac. Phosphorylation at serine 192 (S192) represents a critical regulatory event in PAK2 activation and function. This specific phosphorylation site plays a crucial role in regulating cell migration, proliferation, and survival pathways . Dysregulation of PAK2 activity through abnormal phosphorylation has been linked to various pathological conditions, including cancer, inflammatory disorders, and neurological conditions .

Functionally, S192 phosphorylation occurs within the regulatory domain of PAK2 and contributes to the conformational changes required for full kinase activation. Unlike the more extensively studied autophosphorylation site at T402/T423 (PAK2/PAK1), S192 represents a distinct regulatory mechanism that may be controlled by upstream kinases in various signaling contexts .

What detection methods are available for Phospho-PAK2 (S192)?

Several methodological approaches are available for detecting Phospho-PAK2 (S192):

For optimal results, researchers should validate antibody specificity using appropriate controls, including: (1) dephosphorylation treatments, (2) competitive blocking with phosphopeptides, and (3) siRNA knockdown of PAK2 to confirm signal specificity .

How do I troubleshoot non-specific binding in Phospho-PAK2 (S192) Western blotting?

Non-specific binding is a common challenge when working with phospho-specific antibodies. To address this issue:

• Optimize blocking conditions: Use 5% BSA instead of milk, as milk contains phosphoproteins that may interfere with phospho-antibody detection .

• Adjust antibody dilution: For Western blotting, start with a 1:1000 dilution, but optimize based on signal-to-noise ratio. Some antibodies may require dilutions up to 1:2000 for optimal results .

• Include phosphatase inhibitors: Always include phosphatase inhibitors in lysis buffers to preserve phosphorylation status during sample preparation .

• Consider cross-reactivity: Many PAK2 S192 antibodies may cross-react with the homologous phosphorylation site in PAK1 (S199/S204). Verify specificity by comparing band patterns with the predicted molecular weights: PAK1 (68-74 kDa) versus PAK2 (61-67 kDa) .

• Validate with peptide competition: Use blocking peptides containing the phosphorylated S192 epitope to confirm signal specificity .

What are the optimal sample preparation methods for preserving PAK2 S192 phosphorylation?

Preserving phosphorylation status during sample preparation is critical for accurate analysis:

• Cell lysis conditions: Use ice-cold lysis buffer containing both phosphatase inhibitors (sodium orthovanadate, sodium fluoride, β-glycerophosphate) and protease inhibitors. Maintain samples at 4°C throughout processing .

• Tissue processing: For tissues, snap-freezing in liquid nitrogen immediately after collection is essential to prevent phosphatase activity. Process frozen tissues in the presence of phosphatase inhibitors .

• Denaturation conditions: For Western blotting, heat samples at 95°C for 5 minutes in Laemmli buffer containing SDS and reducing agents to ensure complete protein denaturation and epitope accessibility .

• For ELISA applications: When using cell-based ELISA approaches, fixation protocols significantly impact epitope preservation. A recommended approach is 4% paraformaldehyde fixation for 20 minutes at room temperature, followed by gentle permeabilization with 0.1% Triton X-100 .

How can I distinguish between PAK1 and PAK2 phosphorylation in experimental systems?

Distinguishing PAK1 and PAK2 phosphorylation presents a significant challenge due to their high sequence similarity, particularly at the S192/S199 region:

What is the relationship between PAK2 S192 phosphorylation and its kinase activity?

The relationship between S192 phosphorylation and PAK2 kinase activity is complex:

• Regulatory significance: Unlike the well-characterized T402 autophosphorylation site, S192 phosphorylation represents a distinct regulatory mechanism that may precede full kinase activation .

• Correlation with activity: Research has shown that S192 phosphorylation often correlates with PAK2 activation, but this relationship may be context-dependent . In breast cancer cells, phosphorylation at S192/197 in PAK2 has been observed in focal adhesions, correlating with constitutive PAK activation .

• Experimental validation: To determine whether S192 phosphorylation reflects kinase activity in your experimental system:

  • Compare S192 phosphorylation with established readouts of PAK2 activity, such as phosphorylation of downstream substrates (e.g., LIMK, MEK1)

  • Measure PAK2 kinase activity directly using in vitro kinase assays with immunoprecipitated PAK2

  • Generate phospho-mimetic (S192D/E) or phospho-null (S192A) mutants to assess the functional consequences on PAK2 activity

• Focal adhesion localization: Evidence suggests that PAK2 localization to focal adhesions may be required for its activation, and this localization correlates with S192/S197 phosphorylation. Disruption of PAK/PIX interaction, which mediates focal adhesion localization, reduces both phosphorylation at S192/S197 and kinase activity .

How can I design experiments to identify upstream kinases responsible for PAK2 S192 phosphorylation?

Identifying the upstream kinases that phosphorylate PAK2 at S192 requires a strategic experimental approach:

• Bioinformatic prediction: Analyze the sequence motif surrounding S192 using phosphorylation site prediction tools to identify candidate kinases. The S192 site exists within a sequence context that may be recognized by several kinases .

• Kinase inhibitor screening: Systematic treatment of cells with panel of kinase inhibitors followed by assessment of S192 phosphorylation can narrow down potential upstream kinases:

  • Start with broad-spectrum inhibitors (staurosporine) and gradually move to more specific inhibitors

  • Include appropriate positive controls for inhibitor efficacy

  • Verify results using multiple inhibitors with different mechanisms where possible

• Genetic approaches: Overexpression of constitutively active or dominant-negative forms of candidate kinases, or siRNA-mediated knockdown, followed by assessment of PAK2 S192 phosphorylation .

• In vitro kinase assays: Express and purify recombinant PAK2 (kinase-dead mutant) and test candidate kinases for their ability to directly phosphorylate S192 in vitro .

• Chemical genetic approaches: A particularly powerful approach employs analog-sensitive kinase mutants combined with thiophosphate labeling, as described by Shokat lab. This method can identify direct substrates of specific kinases in complex cellular environments .

What are the methodological considerations for analyzing PAK2 S192 phosphorylation dynamics in response to stimuli?

Investigating the temporal dynamics of PAK2 S192 phosphorylation requires careful experimental design:

• Time course optimization: PAK2 phosphorylation at S192 may exhibit transient kinetics following stimulation. Design experiments with multiple time points spanning seconds to hours to capture both rapid and sustained phosphorylation events .

• Stimulation conditions: Common PAK2-activating stimuli include:

  • Growth factors (EGF, PDGF, heregulin β1)

  • Integrin engagement (cell adhesion to ECM)

  • Mechanical stimuli (shear stress, stretch)

  • Small GTPase activators (CNF1, EGF)

• Quantification approaches:

  • For Western blotting: normalize phospho-signal to total PAK2 protein levels

  • For cell-based ELISA: use crystal violet staining for cell number normalization

  • For immunofluorescence: perform pixel intensity analysis normalized to total PAK2 signal

• Single-cell analysis: Population averages may mask important heterogeneity in PAK2 phosphorylation. Consider immunofluorescence or flow cytometry-based approaches to assess phosphorylation at the single-cell level .

• Controlling for confounding factors: Cell density, serum starvation conditions, and cell cycle phase can all influence baseline PAK2 phosphorylation. Standardize these parameters across experiments .

What are the key parameters for optimizing cell-based ELISA for Phospho-PAK2 (S192) detection?

Cell-based ELISA offers advantages for high-throughput analysis of PAK2 phosphorylation, but requires careful optimization:

• Cell density optimization: The dynamic range for most cell-based ELISA kits is >5000 cells per well. Optimize cell density to ensure signal falls within the linear range of detection .

• Fixation and permeabilization conditions: Overfixation can mask epitopes, while insufficient permeabilization limits antibody access. Recommended starting conditions:

  • 4% paraformaldehyde fixation for 20 minutes at room temperature

  • 0.1% Triton X-100 for 10 minutes for permeabilization

• Antibody incubation parameters:

  • Primary antibody: Test different dilutions (1:500-1:2000) and incubation times (2h at RT vs. overnight at 4°C)

  • Secondary antibody: Typically 1:5000 dilution for 1-2 hours at room temperature

• Normalization approach: To account for well-to-well variation in cell number:

  • Dual detection of phospho-PAK2 and total PAK2 in the same well (if using different host species antibodies)

  • Crystal violet staining for total cell normalization

  • Parallel wells with nuclear stain for cell counting

• Signal development optimization: The colorimetric signal development time should be optimized to achieve sufficient signal intensity while remaining in the linear range (typically 5-30 minutes) .

How can I resolve contradictory results between different detection methods for Phospho-PAK2 (S192)?

Contradictory results between different detection methods are common and may reflect methodological differences rather than experimental errors:

• Understand method-specific biases:

  • Western blotting: Detects denatured proteins, may miss conformational effects

  • Cell-based ELISA: Preserves cellular context but may be affected by antibody accessibility

  • Immunofluorescence: Provides spatial information but may lack quantitative precision

• Epitope accessibility considerations: Protein-protein interactions, conformational changes, or competing post-translational modifications may differentially affect epitope accessibility in different assays .

• Control experiments to resolve discrepancies:

  • Validate antibody specificity across all methods using phosphatase treatment

  • Compare results using multiple antibodies targeting the same phospho-site

  • Use genetic approaches (S192A mutants) as definitive controls

• Integrated analysis approach: Rather than relying on a single method, use multiple complementary techniques and look for convergent evidence. Consider each method as providing different yet complementary information about PAK2 phosphorylation status .

What are the considerations for studying PAK2 S192 phosphorylation in different cellular compartments?

PAK2 can localize to multiple cellular compartments, each with distinct regulatory mechanisms and functions:

• Subcellular fractionation approach:

  • Prepare cytosolic, membrane, nuclear, and cytoskeletal fractions

  • Analyze S192 phosphorylation in each fraction by Western blotting

  • Verify fraction purity using compartment-specific markers (e.g., GAPDH, Na+/K+ ATPase, Lamin A/C)

• Immunofluorescence microscopy optimization:

  • Use confocal microscopy for precise spatial localization

  • Co-stain with markers of specific structures (focal adhesions: paxillin; Golgi: GM130; etc.)

  • Consider super-resolution techniques for detailed localization studies

• Compartment-specific regulation:

  • PAK2 in focal adhesions: Co-immunoprecipitation with PIX/GIT complex components may provide insights into focal adhesion-specific regulation of S192 phosphorylation

  • Nuclear PAK2: Examine relationship between nuclear localization and S192 phosphorylation status

• Technical considerations for compartment-specific analysis:

  • Different fixation/permeabilization protocols may be required for optimal detection in different compartments

  • Antibody accessibility may vary between compartments due to protein-protein interactions

How should I approach PAK2 S192 phosphorylation analysis in tissue samples?

Analyzing PAK2 S192 phosphorylation in tissue samples presents unique challenges:

• Tissue preservation considerations:

  • Snap-freeze tissues immediately after collection to preserve phosphorylation status

  • Consider perfusion fixation for optimal morphological preservation while maintaining phospho-epitopes

• Extraction protocols for biochemical analysis:

  • Use tissue-specific homogenization buffers with phosphatase inhibitors

  • Consider specialized extraction protocols for tissues with high protease/phosphatase activity (e.g., brain, pancreas)

• Immunohistochemistry optimization:

  • Antigen retrieval methods may impact phospho-epitope detection; compare heat-induced (citrate, EDTA) and enzymatic methods

  • Background reduction: Consider specialized blocking reagents for tissues with high endogenous biotin or peroxidase activity

  • Validation using phosphatase-treated serial sections as negative controls

• Context-specific controls:

  • Include normal adjacent tissue as internal control

  • Consider phospho-null knockin animal models for definitive validation

  • Use multiple antibodies targeting different PAK2 epitopes to confirm specificity

How does PAK2 S192 phosphorylation differ functionally from other PAK2 phosphorylation sites?

PAK2 contains multiple phosphorylation sites that regulate its activity and function through distinct mechanisms:

S192 phosphorylation differs from these other sites in several key aspects:

• Regulatory mechanism: Unlike T402, which is primarily an autophosphorylation site, S192 appears to be targeted by upstream kinases, potentially including AMPK as suggested by phosphoproteomics studies .

• Temporal dynamics: S192 phosphorylation may precede T402 autophosphorylation in some activation contexts, suggesting it may play a role in the initial steps of PAK2 activation .

• Localization effects: Evidence suggests S192 phosphorylation correlates with focal adhesion localization, whereas other phosphorylation sites may regulate different aspects of PAK2 localization and function .

• Disease relevance: Altered S192 phosphorylation patterns have been observed in cancer cells, particularly in breast cancer, suggesting distinct pathological roles compared to other phosphorylation sites .

What experimental approaches can determine if PAK2 S192 phosphorylation is dysregulated in disease models?

Investigating PAK2 S192 phosphorylation in disease contexts requires systematic approaches:

• Comparative analysis in disease vs. normal tissues/cells:

  • Western blot analysis comparing phospho-S192 levels normalized to total PAK2

  • Tissue microarray immunohistochemistry to assess phosphorylation patterns across large sample cohorts

  • Phosphoproteomics to quantitatively assess S192 phosphorylation in complex samples

• Correlation with disease progression:

  • Analyze S192 phosphorylation across disease stages (e.g., cancer grades, inflammatory disease progression)

  • Assess correlation with clinical outcomes and therapeutic responses

• Functional consequences:

  • Compare cellular phenotypes (migration, proliferation, survival) with S192 phosphorylation status

  • Express phospho-mimetic (S192D/E) or phospho-null (S192A) mutants to determine functional consequences

  • Identify and validate downstream effectors specifically regulated by S192 phosphorylation

• In vivo models:

  • Generate knock-in mouse models expressing phospho-null (S192A) PAK2 to assess physiological consequences

  • Use patient-derived xenografts to study S192 phosphorylation in heterogeneous human tumors

How can I design experiments to test the causal relationship between PAK2 S192 phosphorylation and cellular functions?

Establishing causality between S192 phosphorylation and specific cellular functions requires rigorous experimental design:

• Phospho-mutant approaches:

  • Generate stable cell lines expressing PAK2 with S192A (phospho-null) or S192D/E (phospho-mimetic) mutations

  • Rescue experiments in PAK2-depleted backgrounds

  • CRISPR/Cas9-mediated genomic editing of endogenous PAK2 to introduce phospho-mutants

• Temporal control strategies:

  • Use optogenetic approaches to spatiotemporally control upstream pathways leading to S192 phosphorylation

  • Employ rapidly-acting chemical inhibitors with careful time course analysis

  • Consider chemical-genetic approaches for specific and rapid inhibition of PAK2 activity

• Pathway validation:

  • Identify and validate both upstream regulators and downstream effectors of S192 phosphorylation

  • Use epistasis experiments to place S192 phosphorylation within signaling hierarchies

  • Employ phospho-specific interactome analysis to identify binding partners specific to the S192-phosphorylated form

• Quantitative analysis:

  • Establish dose-response relationships between the degree of S192 phosphorylation and functional outcomes

  • Use correlation analysis with appropriate statistical methods to assess strength of relationships

  • Consider multivariate analysis to account for the influence of other PAK2 phosphorylation sites

What are the most effective experimental designs for studying PAK2 S192 phosphorylation in complex cellular contexts?

Studying PAK2 S192 phosphorylation in complex systems requires sophisticated experimental approaches:

• 3D culture systems and organoids:

  • Compare PAK2 S192 phosphorylation patterns between 2D cultures and 3D models

  • Assess phosphorylation in response to matrix stiffness and composition

  • Use immunofluorescence with optical clearing techniques for deep tissue imaging

• Co-culture models:

  • Investigate PAK2 S192 phosphorylation at cell-cell interfaces in heterotypic cultures

  • Use cell type-specific markers to distinguish phosphorylation patterns in different populations

  • Consider conditioned media experiments to identify soluble factors regulating S192 phosphorylation

• In vivo approaches:

  • Develop phospho-S192-specific antibodies suitable for intravital imaging

  • Use tissue-specific or inducible expression of PAK2 phospho-mutants

  • Consider interspecies differences when translating findings across model organisms

• Single-cell analysis:

  • Implement phospho-flow cytometry for quantitative single-cell analysis of S192 phosphorylation

  • Combine with other markers to identify cell-type specific phosphorylation patterns

  • Consider mass cytometry (CyTOF) for multiplexed analysis of PAK2 phosphorylation in conjunction with other signaling nodes

How can phosphoproteomics approaches enhance our understanding of PAK2 S192 phosphorylation?

Advanced phosphoproteomics technologies offer powerful approaches for studying PAK2 S192 phosphorylation in complex systems:

• Global phosphoproteome analysis:

  • Quantify changes in S192 phosphorylation across diverse experimental conditions

  • Identify co-regulated phosphorylation sites on PAK2 and other proteins

  • Compare phosphorylation stoichiometry across different tissues and cell types

• Proximity-based phosphoproteomics:

  • BioID or APEX2 fusion with PAK2 to identify proximal proteins in different phosphorylation states

  • Spatially-resolved phosphoproteomics to analyze compartment-specific phosphorylation networks

  • Crosslinking mass spectrometry to capture phosphorylation-dependent interaction partners

• Kinase-substrate relationship mapping:

  • Chemical-genetic approaches (as outlined by Shokat lab) can identify direct AMPK substrates, including PAK2 S192

  • Kinase assays coupled with mass spectrometry for unbiased identification of substrates

  • Computational integration of phosphoproteomics data with kinase prediction algorithms

• Temporal dynamics analysis:

  • Pulse-chase SILAC combined with phosphopeptide enrichment to determine S192 phosphorylation turnover rates

  • Multiplexed quantitative phosphoproteomics using tandem mass tags (TMT) for high-resolution time course experiments

  • Integration with phosphatase inhibitor studies to assess regulation by both kinases and phosphatases

What novel imaging techniques can be applied to study spatial regulation of PAK2 S192 phosphorylation?

Emerging imaging technologies provide unprecedented insights into spatial aspects of PAK2 phosphorylation:

• FRET-based biosensors:

  • Design intramolecular FRET sensors that report on S192 phosphorylation state

  • Combine with optogenetic tools for simultaneous perturbation and monitoring

  • Implement high-throughput imaging to screen for regulators of S192 phosphorylation

• Super-resolution microscopy:

  • Apply STORM/PALM techniques to visualize nanoscale distribution of phosphorylated PAK2 in focal adhesions

  • Use expansion microscopy to physically enlarge structures for enhanced resolution

  • Implement lattice light-sheet microscopy for high-speed 3D imaging of phosphorylation dynamics

• Specific labeling strategies:

  • Develop cell-permeable phospho-specific probes based on antibody fragments or synthetic binding proteins

  • Apply proximity ligation assays to visualize interactions specific to phosphorylated PAK2

  • Utilize split fluorescent protein complementation to detect phosphorylation-dependent protein interactions

• In vivo imaging approaches:

  • Generate transgenic models expressing optical reporters of PAK2 activity

  • Apply intravital microscopy to monitor phosphorylation dynamics in native tissue environments

  • Use correlative light and electron microscopy to link phosphorylation patterns with ultrastructural features

How might systems biology approaches integrate PAK2 S192 phosphorylation into broader signaling networks?

Systems-level analysis provides context for understanding PAK2 S192 phosphorylation within complex signaling networks:

• Network modeling approaches:

  • Construct directed signaling graphs incorporating PAK2 S192 phosphorylation

  • Apply Bayesian network analysis to infer causal relationships

  • Develop ordinary differential equation models to capture temporal dynamics of PAK2 regulation

• Multi-omics integration:

  • Correlate S192 phosphorylation patterns with transcriptomic changes

  • Link phosphoproteomics and interactomics data to identify phosphorylation-dependent interaction networks

  • Incorporate metabolomics data to connect PAK2 signaling with metabolic regulation

• Perturbation biology:

  • Systematic perturbation with genetic and pharmacological tools

  • Apply machine learning to predict network responses to novel perturbations

  • Identify context-dependent vulnerabilities in PAK2-dependent networks

• Cross-disease comparative analysis:

  • Compare PAK2 S192 phosphorylation networks across different pathological contexts

  • Identify conserved and disease-specific regulatory mechanisms

  • Apply network medicine approaches to position PAK2 within disease modules